CoChat

Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)

Bourguet, Erika, Ozdarska, Katarzyna, Moroy, Gautier, Jeanblanc, Jérôme, Naassila, Mickaël · 2018 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.

Abstract

Alcohol use disorder (AUD) represents a serious public health issue, and discovery of new therapies is a pressing necessity. Alcohol exposure has been widely demonstrated to modulate epigenetic mechanisms, such as histone acetylation/deacetylation balance, in part via histone deacetylase (HDAC) inhibition. Epigenetic factors have been suggested to play a key role in AUD. To date, 18 different mammalian HDAC isoforms have been identified, and these have been divided into four classes. Since recent studies have suggested that both epigenetic mechanisms underlying AUD and the efficacy of HDAC inhibitors (HDACIs) in different animal models of AUD may involve class I HDACs, we herein report the development of class I HDACIs, including information regarding their structure, potency, and selectivity. More effort is required to improve the selectivity, pharmacokinetics, and toxicity profiles of HDACIs to achieve a better understanding of their efficacy in reducing addictive behavior.

Overview

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.7b00115

Cites

113 of 113 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 113 references

Research works printed but not linked: 6

  1. 2015, Global Status Report on Alcohol and Health 2014
  2. Polich, J. M.; Armor, D. J.; Braiker, H. B. Stability and Change in Drinking Patterns in the Course of Alcoholism: Four Years after Treatment . John Wiley & Sons: New York, 1981; pp 159–200.
  3. 2014, Une Recommandation Temporaire d’Utilisation (RTU) Est Accordée pour le Baclofène—Point d’Information
  4. Starkman B. G., 2012, Alcohol Res., 34, 293
  5. Wang C., 2013, Am. J. Nucl. Med. Mol. Imaging, 4, 29
  6. Furumai R., 2002, Cancer Res., 62, 4916

Cited by

See all 39

Metadata

Authors
Bourguet, E., Ozdarska, K., Moroy, G., Jeanblanc, J., & Naassila, M.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
  • INSERM ERi 24, Groupe de Recherche sur l’Alcool et les Pharmacodépendances (GRAP), Université de Picardie Jules Verne, C.U.R.S. (Centre Universitaire de Recherche en Santé), Chemin du Thil, 80000 Amiens, France
Corresponding author
Bourguet, Erika
Venue
Journal of Medicinal Chemistry
Published
2017-08-03
Volume
61
Issue
5
Pages
1745-1766
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2745028397
Cited by
36
References
113
Citations by year
2026: 2 · 2025: 7 · 2024: 3 · 2023: 8 · 2022: 2 · 2021: 6 · 2020: 4 · 2019: 2 · 2018: 2
FWCI
0.20
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • Minist?re de l'Enseignement Sup?rieur et de la Recherche
  • Centre National de la Recherche Scientifique
  • Conseil R?gional de Picardie
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme function and inhibition
Keywords
class I HDAC inhibitors, histone deacetylase, alcoholism, epigenetic therapy, histone acetylation, HDAC isoforms, structure-activity relationship, drug selectivity, pharmacokinetics, toxicity, addictive behavior
MeSH terms
Alcoholism, Animals, Humans, Therapeutics, Histone Deacetylase Inhibitors, Epigenomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD). https://app.cochat.ai/papers/10.1021/acs.jmedchem.7b00115
The paper
Bourguet, E., Ozdarska, K., Moroy, G., Jeanblanc, J., & Naassila, M. (2018). Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD). Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00115

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.